FLWPF (The Flowr) Common Stock: $212.98 Mil (As of Sep. 2022)


What is The Flowr Common Stock?

The Flowr FLWPF -90.00% Common Stock is $212.98 Mil as of Sep. 2022.

The Flowr's quarterly common stock declined from Mar. 2022 ($223.42 Mil) to Jun. 2022 ($221.88 Mil) and declined from Jun. 2022 ($221.88 Mil) to Sep. 2022 ($212.98 Mil).

The Flowr's annual common stock increased from Dec. 2019 ($136.26 Mil) to Dec. 2020 ($206.56 Mil) and increased from Dec. 2020 ($206.56 Mil) to Dec. 2021 ($220.98 Mil).

The Flowr Common Stock Historical Data

* Premium members only.

The historical data trend for The Flowr's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Flowr Common Stock Chart

The Flowr Annual Data
Trend Jun17 Jun18 Dec19 Dec20 Dec21
Common Stock
0.16 0.29 136.26 206.56 220.98

The Flowr Quarterly Data
Sep17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 222.67 220.98 223.42 221.88 212.98

The Flowr Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $212.98 Mil mean?
The Flowr (FLWPF) has a Common Stock of $212.98 Mil as of Sep. 2022. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on The Flowr and its competitors.
Is The Flowr's Common Stock too high?
The Flowr's current Common Stock is $212.98 Mil.
How does The Flowr's Common Stock compare to ZTS and CTLT?
The Flowr's Common Stock of $212.98 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on The Flowr and its competitors. The Flowr's current Common Stock is $212.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Flowr stock overvalued right now?
The Flowr (FLWPF) has a current Common Stock of $212.98 Mil. The current Common Stock is $212.98 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For The Flowr (FLWPF), the current Common Stock is $212.98 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Flowr Business Description

Address 365 Bay Street, Suite 800, Toronto, ON, CAN, M5H 2V1
The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.